ArticleYonsei medical journal2026
Serial Optical Coherence Tomography Assessment of Plaque Phenotype Stabilization after Paclitaxel-Coated Balloon Treatment in De Novo Coronary Lesions.
Article in Yonsei medical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThere is limited evidence regarding serial plaque changes after paclitaxel-coated balloon (PCB) treatment in de novo coronary target lesions assessed using optical coherence tomography (OCT). MATERIALS AND
methodsA prospective serial OCT was performed on de novo target lesions in 48 patients (50 lesions) who underwent PCB treatment. Follow-up OCT was conducted for all lesions after a median of 6 months. The primary analysis evaluated changes in minimum fibrous cap thickness and maximum lipid arc across the imaged lesion segment.
resultsIn 2550 matched cross-sections from the analyzed lesions, the minimum fibrous cap thickness increased from 40.0±15.1 µm to 46.6±15.7 µm (
conclusionAt 6 months after PCB treatment, target-lesion plaques exhibited OCT-derived changes consistent with a shift toward a less vulnerable plaque phenotype. The clinical implications of these imaging findings require further investigation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.